Logo-jnp
Review Article

1. Nephroprotection and chemotherapy sensitivity impact of metformin during cisplatin therapy; an updated review
Mohsen Akhavan Sepahi* ORCID, Sarvenaz Mehrabi ORCID, Rohollah Valizadeh ORCID, Steven James Kellner, Azin Mirzazadeh ORCID, Semko Ebrahimi ORCID
J Nephropathol. 2019;8(4): e45. doi: 10.15171/jnp.2019.45
Scopus ID: 85074967863    
Article
PDF
XML
Cited By:
2
0
Review

2. Administration of metformin in type 2 diabetes mellitus patients with chronic kidney disease; facts and myths
Mohsen Akhavan Sepahi* ORCID, Bhaskar VKS Lakkakula ORCID, Steven James Kellner ORCID, Rohollah Valizadeh ORCID
J Nephropathol. 2020;9(1): e04. doi: 10.15171/jnp.2020.04
Scopus ID: 85078239703    
Article
PDF
XML
Cited By:
4
2
Epidemiology and Prevention

3. Multifaceted role of apolipoprotein L1 risk variants and nephropathy
Mohsen Akhavan Sepahi ORCID, Bahram Niknafs* ORCID
J Nephropathol. 2020;9(1): e03. doi: 10.15171/jnp.2020.03
Scopus ID: 85078296609    
Article
PDF
XML
Cited By:
1
1
News and Views

4. Autophagy and treatment of patients with COVID-19; which drugs target the autophagy pathway?
Elahe Aleebrahim-Dehkordi ORCID, Shirin Saberianpour ORCID, Ebrahim Soleiman-Dehkordi ORCID, Dariush Hooshyar ORCID, Zahra Mojtahedi ORCID, Neda Kianpour ORCID, Ali Hasanpour-Dehkordi* ORCID, Lillian Saberian ORCID, Mohsen Akhavan Sepahi* ORCID
J Nephropathol. 2022;11(1): e1. doi: 10.34172/jnp.2022.01
Scopus ID: 85118106361    
Article
PDF
XML
Cited By:
2
0

Review Article

5. Administration of finerenone in chronic kidney disease
Mohsen Akhavan Sepahi ORCID, Elham Emami ORCID, Akshaya Ann Joseph ORCID, Shakiba Hassanzadeh ORCID, Mohammad Reza Razavi* ORCID
J Nephropathol. 2023;12(1): e17355. doi: 10.34172/jnp.2022.17355
Scopus ID: 85148954878    
Article
PDF
XML
Cited By:
0
1